Drreddys Laboratories | RDY - DEBITO





DEBITO Cambiamento Data
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Canopy Growth CAD 278.71M 19.38M 2026-03
Cipla INR 4.38B 231.9M 2025-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Drreddys Laboratories INR 77.34B 9.61B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Lonza CHF 4.71B 915M 2024-12
Novartis USD 47B 11.62B 2026-03
Pacira USD 367.66M 4.53M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.08B 38.27M 2025-12
Richter Gedeon HUF 21.74B 1.93B 2024-12
Sun Pharmaceuticals INR 23.62B 2.1B 2025-03
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12